Adamant Health

company

About

Better days for people with Parkinson’s disease.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
€2.20M
Industries
Health Care,Medical Device
Founded date
Aug 24, 2020
Number Of Employee
1 - 10
Operating Status
Active

Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objective and long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€2.20M
Adamant Health has raised a total of €2.20M in funding over 2 rounds. Their latest funding was raised on Jun 13, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 13, 2022 Seed €2.20M 1 Detail
Dec 15, 2020 Pre-seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Adamant Health is funded by 1 investors. Cor Group are the most recent investors.
Investor Name Lead Investor Funding Round
Cor Group Seed